1. Quality of life in patients with vitiligo: an analysis of the dermatology life quality index outcome over the past two decades;Amer;Int. J. Dermatol.,2016
2. Melanocyte-specific cytotoxic T lymphocytes in patients with rhododendrol-induced leukoderma;Fujiyama;J. Dermatol. Sci.,2015
3. The first epidemiological report of rhododenol-induced leukoderma in Japan based on a nationwide survey;Aoyama;Jpn. J. Dermatol,2014
4. The second epidemiology report of rhododenol-induced leukoderma in Japan based on a nationwide survey;Suzuki;Jpn. J. Dermatol.,2014
5. Assessment methods for the evaluation of vitiligo;Alghamdi;J. Eur. Acad. Dermatol. Venereol.,2012